Pharmaceutical

BridgeBio Oncology Therapeutics launches with $200m funding

BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.

May 5, 2024 - 00:00
BridgeBio Oncology Therapeutics launches with $200m funding
BridgeBio Pharma has announced the launch of BridgeBio Oncology Therapeutics (BBOT), underpinned by $200m of private external capital.
Read the original article

Tags:

Previous Article

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

Next Article

Optimisation in operations: from theory to practice

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The scientist studying how fugitive fetal cells may affect maternal health

The scientist studying how fugitive fetal cells may aff...

Nov 1, 2023

STAT+: The quest for psychedelics in the Amazon would push a Harvard botanist to his limits

STAT+: The quest for psychedelics in the Amazon would p...

Feb 27, 2024

Which drugs are most likely to be approved in Stem Cell...

Mar 28, 2024